GLP-1 receptor agonists (GLP-1 RAs), already established in the management of type 2 diabetes mellitus and obesity, have emerged as promising candidates for the treatment of nonalcoholic steatohepatitis (NASH), owing to their broad metabolic and hepatoprotective effects
The Journal of endocrinology , 165 (3), 569577.
Drugs like Ozempic and Mounjaro are only approved for use in the treatment of Type 2 diabetes
31 In contrast to MEDI-573, BI836845 administration increased IGF-1 serum concentrations
ADA 2026 emphasizes individualized care in older adults, with attention to nutrition, functional status, and overtreatment avoidance Thyroid caution Avoid in: Medullary thyroid carcinoma (MTC) MEN-2 syndrome This remains a boxed warning / contraindication in current labels
This prospective study demonstrates the importance of offering genetic screening to all patients with ALS irrespective of a family history of the disease